🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lih‐Chu Chiou

National Taiwan University

ORCID: 0000-0001-5356-940X

Also affiliated with China Medical University

MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice”.

Median Nerve Stimulation as a Nonpharmacological Approach to Bypass Analgesic Tolerance to Morphine: A Proof-of-Concept Study in Mice

Journal of Pain(2020)10.1016/j.jpain.2020.09.003
N/A
0DataRank · unranked
11 citations

Yi‐Hung Chen, Ken Mackie, Lih‐Chu Chiou, Ming Tatt Lee

α6GABAA Receptor Positive Modulators Alleviate Migraine-like Grimaces in Mice via Compensating GABAergic Deficits in Trigeminal Ganglia

Neurotherapeutics(2020)10.1007/s13311-020-00951-1
N/A
0DataRank · unranked
28 citations

Ming Tatt Lee, Pi‐Chuan Fan, Daniel E. Knutson, Tzu-Hsuan Lai, Werner Sieghart +3 more

Alternative pain management via endocannabinoids in the time of the opioid epidemic: Peripheral neuromodulation and pharmacological interventions

British Journal of Pharmacology(2021)10.1111/bph.15771
N/A
0DataRank · unranked
12 citations

Ken Mackie, Lih‐Chu Chiou, Ming Tatt Lee

Positive modulation of cerebellar α6GABA A receptors for treating essential tremor: a proof-of-concept study in harmaline-treated mice

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.04.19.440397
N/A
0DataRank · unranked
3 citations

Ming Tatt Lee, Werner Sieghart, Daniel E. Knutson, Laurin Wimmer, Dishary Sharmin +4 more

Targeting α6GABAA receptors as a novel therapy for schizophrenia: A proof-of-concept preclinical study using various animal models

Biomedicine & Pharmacotherapy(2022)10.1016/j.biopha.2022.113022
N/A
0DataRank · unranked
17 citations

Akihiro Mouri, Hisayoshi Kubota, Hsin‐Jung Lee, Man‐Hsin Chang, Chen-Yi Wu +7 more

Cerebellar α6GABAA Receptors as a Therapeutic Target for Essential Tremor: Proof-of-Concept Study with Ethanol and Pyrazoloquinolinones

Neurotherapeutics(2023)10.1007/s13311-023-01342-y
N/A
0DataRank · unranked
17 citations

Ming Tatt Lee, Han-Yun Hsueh, Daniel E. Knutson, James M. Cook, Marko D. Mihovilovič +3 more

The deuterated pyrazoloquinolinone targeting α6 subunit-containing GABAA receptor as novel candidate for inhibition of trigeminovascular system activation: implication for migraine therapy

Frontiers in Pharmacology(2024)10.3389/fphar.2024.1451634
N/A
0DataRank · unranked
6 citations

Lih‐Chu Chiou, Tzu-Hsuan Lai, Dishary Sharmin, James M. Cook, Ming Tatt Lee +1 more

α6GABAA receptor positive allosteric modulators targeting trigeminal ganglia for preventing and aborting chronic periorbital allodynia and cephalic pain in both sexes: A mechanistic and comparative preclinical study

Biomedicine & Pharmacotherapy(2025)10.1016/j.biopha.2025.118344
N/A
0DataRank · unranked
2 citations

Chen‐Jiun Yeh, Yi-Ting Pan, Yueh-Peng Chen, Dishary Sharmin, James M. Cook +3 more